BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 8460492)

  • 1. Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain.
    Arias CF; Preugschat F; Strauss JH
    Virology; 1993 Apr; 193(2):888-99. PubMed ID: 8460492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever virus NS2B-NS3 protease: charged-to-alanine mutagenesis and deletion analysis define regions important for protease complex formation and function.
    Droll DA; Krishna Murthy HM; Chambers TJ
    Virology; 2000 Sep; 275(2):335-47. PubMed ID: 10998334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing.
    Lin C; Chambers TJ; Rice CM
    Virology; 1993 Feb; 192(2):596-604. PubMed ID: 8421901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
    Niyomrattanakit P; Winoyanuwattikun P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
    J Virol; 2004 Dec; 78(24):13708-16. PubMed ID: 15564480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The active essential CFNS3d protein complex.
    Melino S; Fucito S; Campagna A; Wrubl F; Gamarnik A; Cicero DO; Paci M
    FEBS J; 2006 Aug; 273(16):3650-62. PubMed ID: 16911516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal processing of hepatitis C virus NS3 protein.
    Shoji I; Suzuki T; Sato M; Aizaki H; Chiba T; Matsuura Y; Miyamura T
    Virology; 1999 Feb; 254(2):315-23. PubMed ID: 9986797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.
    Matusan AE; Pryor MJ; Davidson AD; Wright PJ
    J Virol; 2001 Oct; 75(20):9633-43. PubMed ID: 11559795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese encephalitis virus NS2B-NS3 protease binding to phage-displayed human brain proteins with the domain of trypsin inhibitor and basic region leucine zipper.
    Lin CW; Lin KH; Lyu PC; Chen WJ
    Virus Res; 2006 Mar; 116(1-2):106-13. PubMed ID: 16289409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases.
    Jan LR; Yang CS; Trent DW; Falgout B; Lai CJ
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():573-80. PubMed ID: 7897348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
    Murthy HM; Judge K; DeLucas L; Padmanabhan R
    J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A.
    Yamashita T; Unno H; Mori Y; Tani H; Moriishi K; Takamizawa A; Agoh M; Tsukihara T; Matsuura Y
    Virology; 2008 Apr; 373(2):426-36. PubMed ID: 18201743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of the NS3 protease of dengue virus type 2.
    Valle RP; Falgout B
    J Virol; 1998 Jan; 72(1):624-32. PubMed ID: 9420267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
    Zhou H; Singh NJ; Kim KS
    Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies against dengue NS2B and NS3 proteins for the study of protein interactions in the flaviviral replication complex.
    Moreland NJ; Tay MY; Lim E; Rathore AP; Lim AP; Hanson BJ; Vasudevan SG
    J Virol Methods; 2012 Jan; 179(1):97-103. PubMed ID: 22040846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease.
    Yang SH; Lee CG; Song MK; Sung YC
    Virology; 2000 Mar; 268(1):132-40. PubMed ID: 10683335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease.
    Lin CW; Huang HD; Shiu SY; Chen WJ; Tsai MH; Huang SH; Wan L; Lin YJ
    Virus Res; 2007 Jul; 127(1):88-94. PubMed ID: 17467838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity.
    Kim DW; Gwack Y; Han JH; Choe J
    Biochem Biophys Res Commun; 1995 Oct; 215(1):160-6. PubMed ID: 7575585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.